Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020094614 - ANTI-GLYCAN VACCINES

Publication Number WO/2020/094614
Publication Date 14.05.2020
International Application No. PCT/EP2019/080185
International Filing Date 05.11.2019
IPC
A61K 39/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
C07K 14/005 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
CPC
C07K 14/005
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
C12N 2795/18122
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2795Bacteriophages
00011Bacteriophages
18011ssRNA Bacteriophages positive-sense
18111Leviviridae
18122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N 2795/18123
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2795Bacteriophages
00011Bacteriophages
18011ssRNA Bacteriophages positive-sense
18111Leviviridae
18123Virus like particles [VLP]
Applicants
  • ETH ZURICH [CH]/[CH]
  • UNIVERSITY OF BERN [CH]/[CH]
Inventors
  • AEBI, Markus
  • WETTER, Michael
  • BACHMANN, Martin
  • KEYS, Timothy, Gerard
  • TYTGAT, Hanne, Lore
Agents
  • KASCHE, André
Priority Data
18204509.606.11.2018EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ANTI-GLYCAN VACCINES
(FR) VACCINS ANTI-GLYCANE
Abstract
(EN)
The present invention is directed to a self-assembling glycosylated capsid polypeptide, wherein the capsid polypeptide comprises at least one 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo)- glycosylation. The present invention is also directed to a method for producing the self-assembling glycosylated capsid polypeptide, related compositions comprising the glycosylated capsid polypeptide, as well as to related medical uses.
(FR)
La présente invention concerne un polypeptide de capside glycosylé à auto-assemblage, le polypeptide de capside comprenant au moins une glycosylation d'acide 3-désoxy-D-manno-oct-2-ulosonique (Kdo). La présente invention concerne également un procédé de production du polypeptide de capside glycosylé à auto-assemblage, des compositions associées comprenant le polypeptide de capside glycosylé, ainsi que des utilisations médicales associées.
Also published as
Latest bibliographic data on file with the International Bureau